 |
|
|
|
 |
|
|
| Article 1 to 2 out of 2 concerning Daiichi Pharmaceuticals, Co. Ltd.
|
-
YM Biosciences Licenses Monoclonal Antibody, Nimotuzumab, to Daiichi Pharmaceutical for Japan
(08/02/2006)
YM BioSciences Inc. announced that its majority owned subsidiary, CIMYM BioSciences Inc., has licensed development and marketing rights in Japan for its anti-EGFR humanized antibody, nimotuzumab, to Daiichi Pharmaceutical Co., Ltd. (a wholly owned ...
-
Daiichi Enters Funded Research Agreement With Cyntellect
(04/01/2005)
Cyntellect, Inc., a privately-held biotechnology company, announced the company has entered into a research agreement with Daiichi Pharmaceutical Co., Ltd. ("Daiichi") to utilize Cyntellect's high-throughput cell imaging and laser-based cell ...
|
|
|
|
|
Top